Mesothelioma Cancer Resources Blog
-
CD200: A Putative Therapeutic Target in Cancer
Source: CD200: A Putative Therapeutic Target in Cancer One of the most exciting developments in cancer research is the increasing knowledge we have of the biological and biochemical processes involved in tumor development. Scientists are still years away from fully mapping the structural components of tumors, but they have successfully identified a number of proteins …
Label: Cancer Mesothelioma
Posted on Friday, Dec 28, 2007 -
The Role of Video-Assisted Thoracoscopic Pleurectomy/ Decortication in the Therapeutic Management of Malignant Pleural Mesothelioma
Source: Nakas A, et al., The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma, Eur J Cardiothorac Surg (2007), doi:10.1016/j.ejcts.2007.09.039 Mesothelioma is among the most difficult cancers to treat effectively and no true cure exists for this asbestos-caused disease. However, there is an active and creative research community regularly …
Label: Mesothelioma
Posted on Friday, Dec 28, 2007 -
Hospitals Look to Nuclear Tool to Fight Cancer
Source: New York Times The New York Times is running an article on one of the most cutting-edge—and most expensive—cancer treatments: proton beam therapy. Hospitals are using particle accelerators, which are machines that accelerate subatomic particles to speeds nearly that of the speed of light, to shoot protons directly into tumors. Proponents of this therapy, …
Label: Cancer
Posted on Thursday, Dec 27, 2007
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.